BEPREVE

bausch & lomb inc🇨🇦 Health Canada

Approval Id: f05f7b7c3e31e4c6
Drug Approval Canada Name: BEPREVE
Product Name: BEPREVE
Status: Marketed
Status Date: 2017-03-23
Original Market Date: 2017-03-23
Din: 02456532
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Ophthalmic
Schedule: Prescription
Ahfs: 52:02.00
Atc Original: S01 OPHTHALMOLOGICALS
Atc Name: s 01
Aig Number: 0158330001
Company Name: bausch & lomb inc
Company Address: 1400 N Goodman Street, Rochester, New York, United States, 14609

BEPOTASTINE BESILATE

1.5 % / W/V

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

f05f7b7c3e31e4c6

Type

Standard